Description
Overview
IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic analogue of human IGF-1 designed with an extended half-life and reduced binding to IGF-binding proteins. It is frequently selected by research teams working on muscle hypertrophy models, anabolic signaling pathways, and recovery support studies. Our IGF-1 LR3 peptide is engineered in China for international lab partners and supplied as high-purity, pharmaceutical-grade lyophilized powder.
Composition & Format
Active compound: IGF-1 LR3 peptide (Long R3 insulin-like growth factor 1)
Available strengths: 0.1 mg and 1 mg per vial
Standard kit size: 10 vials/kit (1 mg or 10 mg total peptide per kit)
Formulation: White lyophilized powder in sterile glass vials with butyl stoppers and aluminum crimp caps
Manufacturing: China-based facility with pharmaceutical-grade processes and batch documentation available
Key Features for Wholesale Buyers
High-purity IGF-1 LR3 peptide (≥99% purity by typical analytical methods)
Factory-direct supply from a China-based peptide manufacturer focused on export volume
Consistent fill levels and tight batch-to-batch uniformity suitable for recurring purchasing programs
OEM / private-label options for qualified partners (custom caps, labels, and outer boxes on request)
Support for mixed peptide portfolios: IGF-1 LR3 can ship together with GH-related and recovery-focused peptides
Packaging & Ordering
Standard export packaging: 10-vial clear trays with protective lids, multiple trays per outer carton
Each tray is labeled for identification (code, strength, and “For research use only” wording)
Orders are processed with dispatch updates within approximately 3 business days after confirmation
Bulk and repeat orders: contact our team for current pricing, production lead times, and long-term supply planning
OEM / wholesale inquiries are handled directly by our factory-side sales team via email or messaging apps
Storage & Handling
Recommended storage: sealed vials kept at 2–8 °C, protected from light and moisture
For extended storage, lower-temperature conditions may be used according to internal lab SOPs
After reconstitution, solutions should be handled under appropriate sterile conditions and used promptly according to research protocols